Marc R. Pelletier

Discovery of a Novel ERK Inhibitor with Activity in Models of Acquired Resistance to BRAF and MEK Inhibitors

Erick J. Morris, Sharda Jha, Clifford R. Restaino et al. · Cancer Discovery · 2013 · 673 citations · Full text

Pharmacotherapy, Tumor Biology, Drug Resistance +20

Phase I Dose-Escalation Trial of MIW815 (ADU-S100), an Intratumoral STING Agonist, in Patients with Advanced/Metastatic Solid Tumors or Lymphomas

Funda Meric‐Bernstam, Randy F. Sweis, F. Stephen Hodi et al. · Clinical Cancer Research · 2021 · 328 citations · Full text

Reduced Cortical Synaptic Plasticity and GluR1 Expression Associated with Fragile X Mental Retardation Protein Deficiency

Jianxue Li, Marc R. Pelletier, Jose-Luis Perez Velazquez et al. · Molecular and Cellular Neuroscience · 2002 · 260 citations

Synaptic Plasticity, Molecular Neuroscience, Developmental Biology +13

Genomic Analysis of Nasopharyngeal Carcinoma Reveals TME-Based Subtypes

Li Zhang, Kenzie D. MacIsaac, Ting Zhou et al. · Molecular Cancer Research · 2017 · 212 citations

Combination of the STING Agonist MIW815 (ADU-S100) and PD-1 Inhibitor Spartalizumab in Advanced/Metastatic Solid Tumors or Lymphomas: An Open-Label, Multicenter, Phase Ib Study

Funda Meric‐Bernstam, Randy F. Sweis, Stefan Kasper et al. · Clinical Cancer Research · 2022 · 205 citations · Full text